Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-22-000032
Filing Date
2022-08-04
Accepted
2022-08-04 17:08:33
Documents
88
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20220630.htm   iXBRL 10-Q 1877646
2 EX-31.1 ex06302022311.htm EX-31.1 13029
3 EX-31.2 ex06302022312.htm EX-31.2 12487
4 EX-32.1 ex06302022321.htm EX-32.1 8867
5 EX-32.2 ex06302022322.htm EX-32.2 8937
11 GRAPHIC tvtx-20220630_g1.gif GRAPHIC 580484
  Complete submission text file 0001438533-22-000032.txt   10002101

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20220630.xsd EX-101.SCH 53232
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20220630_cal.xml EX-101.CAL 90177
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20220630_def.xml EX-101.DEF 312598
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20220630_lab.xml EX-101.LAB 660489
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20220630_pre.xml EX-101.PRE 455318
82 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20220630_htm.xml XML 1403559
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 221137656
SIC: 2834 Pharmaceutical Preparations